Clinical trials
Not yet recruiting Melanoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Institute of Oncology | 2 |
| Fudan University | 1 |
| Herlev Hospital | 1 |
| Institute of Oncology Ljubljana | 1 |
| Natera, Inc. | 1 |
| OHSU Knight Cancer Institute | 1 |
| Samsung Medical Center | 1 |
| University Hospital, Basel, Switzerland | 1 |
| University of Michigan Rogel Cancer Center | 1 |
| University of Nebraska | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 14 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 2 |
| Adenocarcinoma, Follicular | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cholangiocarcinoma | 1 |
| Colorectal Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.